In positive portfolio news, Deep Blue Medical (March 2019 Dinner) received 510(k) clearance from the Food and Drug Administration (FDA) for its T-Line® Hernia Mesh with integrated suture-like extensions (http://bit.ly/deep-blue-510k).
UNest Portfolio News: Nevertheless She Persisted: How A Female Fintech Founder Raised Her Seed Round
Ksenia Yudina, founder of UNest UNEST
The average annual cost of a private four-year college is $32,410 and a public college (in-state) $9,410, according to the CollegeBoard. College is expensive. More than 44 million Americans owe $1.6 trillion in student debt, writes Zack Friedman, a Forbes contributor. What if there were a way for students to incur no debt or less debt?
Portfolio News: US FDA grants EUA for Cepheid’s SARS-CoV-2 test
Cepheid has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its rapid molecular diagnostic test, Xpert Xpress SARS-CoV-2. The test is designed for the qualitative detection of SARS-CoV-2 virus, which causes coronavirus (Covid-19) disease.
Portfolio News: ClinCapture, Inc. is Providing Free Electronic Data Capture (EDC) for Clinical Researchers Investigating the Treatment of COVID-19 Coronavirus
Band portfolio company ClinCapture, Inc., a leading provider for Electronic Data Capture (EDC) systems and eClinical solutions, announced that it will begin offering EDC at no cost for specific clinical trials investigating COVID-19 Coronavirus. The decision to offer free EDC for BioPharma and Diagnostic companies conducting COVID-19 clinical trials was announced after the World Health Organization issued a statement that the confirmed number of COVID-19 cases has surpassed 100,000 globally.
Portfolio News: CNote Named Emerging Impact Manager on the 2020 Impact Assets 50 List
CNote, an award-winning, first-of-its-kind financial platform that allows anyone to make money investing in causes and communities they care about, was listed as an Emerging Impact Manager on the 2020 Impact Assets 50 list of fund managers